home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Targeting The Transcription Start Site Of DNA

  August, 10 2005 4:18
your information resource in human molecular genetics
A new method of silencing gene expression is reported in the September issue of Nature Chemical Biology. By targeting DNA transcription start sites with peptide nucleic acids (PNAs) researchers have blocked a protein connected to the spread of certain tumours. When bound to the human progesterone receptor (hPR) start site, PNA blocks hPR production, resulting in the upregulation of ezrin, a protein associated with the metastasis of some tumours.

Transcription -- the conversion of genes into RNA copies -- is initiated at sites where polymerase enzymes bind to DNA. Corey and coworkers hypothesized that these transcriptional start sites may be ideal targets for gene silencing approaches. To demonstrate their approach, they targeted the transcription start site of the hPR DNA with an antigene PNA (agPNA). agPNAs directed toward one form of the receptor, hPR-B, potently inhibited hPR-B mRNA production, but also reduced the mRNA levels of hPR-A, a receptor variant. These results suggested an unknown regulatory link between hPR-B and hPR-A expression. Downregulation of hPR in tumor cells by agPNAs changed cell development and enhanced the expression of ezrin, a cytoskeletal protein known to be involved in the metastasis of certain tumors.

The authors showed the usefulness of their approach by blocking gene transcription in live diseased cells, allowing direct observation of the effects of gene silencing. Because every gene contains a DNA transcription start site, this method of controlling transcription initiation could offer a powerful tool for studying cellular processes and potentially treating diseases such as cancer.
Author contact:

David R. Corey
University of Texas Southwestern Medical Center, Dallas, TX, USA)
E-mail: corey@chop.swmed.edu

Additional contact for comment on paper:

Bruce Armitage
Carnegie Mellon University, Pittsburgh, PA, USA)
E-mail: army@andrew.cmu.edu

Abstract available online.

(C) Nature Chemical Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.